Envista (NYSE:NVST) Price Target Raised to $21.00

Envista (NYSE:NVST) had its target price raised by Stifel Nicolaus from $18.00 to $21.00 in a research report report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock.

Other equities research analysts have also recently issued research reports about the company. Bank of America decreased their price objective on Envista from $22.00 to $19.00 and set a “buy” rating on the stock in a report on Thursday, August 8th. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, August 8th. Robert W. Baird decreased their price objective on Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday, July 22nd. Evercore ISI increased their target price on Envista from $18.00 to $23.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. Finally, Wells Fargo & Company initiated coverage on Envista in a research report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 target price on the stock. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $19.88.

Envista Price Performance

Shares of NYSE:NVST opened at $18.90 on Wednesday. The business’s fifty day moving average price is $18.48 and its two-hundred day moving average price is $18.08. The stock has a market cap of $3.25 billion, a PE ratio of -26.24 and a beta of 1.32. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.90 and a current ratio of 2.22. Envista has a one year low of $15.15 and a one year high of $25.64.

Envista (NYSE:NVST) last posted its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.16). Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The business had revenue of $633.10 million for the quarter, compared to analyst estimates of $646.88 million. During the same quarter last year, the business earned $0.43 EPS. Envista’s revenue for the quarter was down 4.4% compared to the same quarter last year. On average, analysts forecast that Envista will post 0.69 EPS for the current fiscal year.

Insider Buying and Selling at Envista

In related news, CFO Eric D. Hammes acquired 24,532 shares of the business’s stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the transaction, the chief financial officer now directly owns 24,532 shares of the company’s stock, valued at $400,607.56. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Envista

Large investors have recently modified their holdings of the business. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Envista during the third quarter valued at about $31,000. GAMMA Investing LLC grew its stake in shares of Envista by 69.8% during the third quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after acquiring an additional 726 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock valued at $39,000 after acquiring an additional 804 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in shares of Envista by 50.8% during the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares in the last quarter. Finally, Versant Capital Management Inc grew its stake in shares of Envista by 1,420.3% during the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock valued at $52,000 after acquiring an additional 2,940 shares in the last quarter.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.